Advances in Head and Neck Cancer Management

Dear Colleagues,

The Special Issue on "Advances in Head and Neck Cancer Management" in the Medicina delves into the multidimensional approach to treating head and neck cancer, including advancements in reconstructive surgery. This collection of articles showcases cutting-edge research aimed at improving outcomes for patients facing the challenges of this complex type of cancer.

Personalized and targeted therapies tailored to the molecular and genetic characteristics of individual tumors are a central theme in this Special Issue. Researchers are exploring novel treatment approaches that maximize efficacy while minimizing side effects, with a particular focus on the role of reconstructive surgery in restoring function and aesthetics post-treatment.

Immunotherapy takes center stage in many articles, highlighting its promise in enhancing the body's immune response against cancer cells. Studies on immunotherapy drugs, such as checkpoint inhibitors, in combination with traditional treatments like chemotherapy and radiation therapy, underscore the potential for improved patient outcomes and quality of life.

Advanced imaging techniques also play a crucial role in the early detection and precise targeting of head and neck tumors, aiding in treatment planning and monitoring responses. Technologies like PET-CT scans and MRIs provide detailed insights into cancer spread, guiding clinicians in making informed decisions throughout the course of treatment, including considerations for reconstructive surgery.

Moreover, the significance of multidisciplinary care is underscored in this Issue, emphasizing the collaborative efforts of oncologists, surgeons, radiation oncologists, speech therapists, and reconstructive surgeons. This team-based approach ensures the comprehensive and holistic management of head and neck cancer, addressing not only the disease itself, but also the functional and aesthetic aspects through reconstructive surgery.

In conclusion, the Special Issue on "Advances in Head and Neck Cancer Management" in Medicina presents a comprehensive overview of the latest advancements in the field. By integrating personalized treatment strategies, immunotherapy innovations, imaging advancements, and the transformative role of reconstructive surgery, this collection of articles encapsulates the multidimensional nature of head and neck cancer care, paving the way for improved patient outcomes and survival.

Prof. Dr. Primož Strojan
Dr. Domen Vozel
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.